Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

4.39
Delayed Data
As of Sep 26
 -0.05 / -1.13%
Today’s Change
2.63
Today|||52-Week Range
6.60
-18.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues683.0K670.0K640.0K610.0K
 
 
 
 
 
Depreciation And Amortization2.0K3.0K3.0K3.0K
 
 
 
 
 
 
Operating ExpensesGross Income------607.0K
 
 
General Expenses9.3M12.0M10.5M10.6M
 
 
 
 
 
Research And Development5.3M7.6M6.2M6.6M
 
 
 
 
 
Total Operating Expenses9.3M12.0M10.5M10.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.6M-11.3M-9.9M-10.0M
 
 
 
 
 
Extraordinary Charge-5.3M0.000.000.00
 
 
Interest Expense On Debt233.0K234.0K298.0K476.0K
 
 
 
 
 
Other Expenses7.1M-4.0K76.0K23.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.0M-11.6M-10.1M-10.4M
 
 
 
 
 
Net Income-7.0M-11.6M-10.1M-10.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.5M12.8M14.4M14.5M
 
 
 
 
 
Shares To Calculate EPS Diluted12.5M12.8M14.4M14.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.54-$0.90-$0.72-$0.72
 
 
 
 
 
EPS Diluted-$0.54-$0.90-$0.72-$0.72